Multiple Myeloma Durie/Salmon Stage
Item
durie-salmon stage ii or iii multiple myeloma
boolean
C0026764 (UMLS CUI [1,1])
C4528204 (UMLS CUI [1,2])
Newly Diagnosed prior to Therapeutic procedure | Induction Therapy Completed
Item
newly diagnosed either prior to receiving treatment or having completed induction therapy
boolean
C1518321 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,3])
C0600558 (UMLS CUI [2,1])
C0205197 (UMLS CUI [2,2])
Recurrent multiple myeloma | Transplantation Absent
Item
relapsed myeloma not previously transplanted within the past 5 years
boolean
C1370446 (UMLS CUI [1])
C0040732 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Availability of Serum M Protein Measurable | Availability of Urine M Protein Measurable | Other Coding
Item
measurable serum and/or urine m-protein from prior to induction therapy documented and available. a positive serum free lite assay is acceptable
boolean
C0470187 (UMLS CUI [1,1])
C0229671 (UMLS CUI [1,2])
C0700271 (UMLS CUI [1,3])
C1513040 (UMLS CUI [1,4])
C0470187 (UMLS CUI [2,1])
C0042036 (UMLS CUI [2,2])
C0700271 (UMLS CUI [2,3])
C1513040 (UMLS CUI [2,4])
C3846158 (UMLS CUI [3])
Age
Item
age greater than 18 years old
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status of 0 - 2
boolean
C1520224 (UMLS CUI [1])
Requirement Fulfill Transplantation of autologous hematopoietic stem cell
Item
meet all institutional requirements for autologous stem cell transplantation
boolean
C1514873 (UMLS CUI [1,1])
C1550543 (UMLS CUI [1,2])
C1831743 (UMLS CUI [1,3])
Informed Consent
Item
the patient must be able to comprehend and have signed the informed consent
boolean
C0021430 (UMLS CUI [1])
Plasma cell disorders | POEMS Syndrome | Non-secretory myeloma
Item
diagnosis of any of the following plasma cell disorders: poems syndrome (plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, monoclonal protein [m-protein] and skin changes) non-secretory myeloma (no measurable protein on serum free lite assay)
boolean
C1136084 (UMLS CUI [1])
C0085404 (UMLS CUI [2])
C0456845 (UMLS CUI [3])
Leukemia, Plasma Cell
Item
plasma cell leukemia
boolean
C0023484 (UMLS CUI [1])
Amyloidosis
Item
amyloidosis
boolean
C0002726 (UMLS CUI [1])
Adrenal Cortex Hormones | Glucocorticoids
Item
use of corticosteroids (glucocorticoids) within 21 days of pre-transplant vaccine or bone marrow collection
boolean
C0001617 (UMLS CUI [1])
C0017710 (UMLS CUI [2])
Therapeutic procedure Myeloma Specific | Exception Lenalidomide
Item
use of any myeloma-specific therapy other than lenalidomide within 21 days of pre-transplant vaccine
boolean
C0087111 (UMLS CUI [1,1])
C0026764 (UMLS CUI [1,2])
C0205369 (UMLS CUI [1,3])
C1705847 (UMLS CUI [2,1])
C1144149 (UMLS CUI [2,2])
In complete remission
Item
in a complete remission at the time of bone marrow collection
boolean
C0677874 (UMLS CUI [1])
Communicable Disease Requirement Antibiotics | Communicable Disease Requirement Antifungal Agents | Communicable Disease Requirement Antiviral Agents
Item
infection requiring treatment with antibiotics, antifungal, or antiviral agents within seven days of vaccination or bone marrow collection
boolean
C0009450 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C0003232 (UMLS CUI [1,3])
C0009450 (UMLS CUI [2,1])
C1514873 (UMLS CUI [2,2])
C0003308 (UMLS CUI [2,3])
C0009450 (UMLS CUI [3,1])
C1514873 (UMLS CUI [3,2])
C0003451 (UMLS CUI [3,3])
Study Subject Participation Status | Investigational New Drugs | Investigational Medical Device
Item
participation in any clinical trial, within four weeks prior to vaccination or bone marrow collection on this trial, which involved an investigational drug or device
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
C2346570 (UMLS CUI [3])
Malignant Neoplasms | Exception Multiple Myeloma | Exception Basal cell carcinoma Treated | Exception Squamous cell carcinoma of skin Treated
Item
history of malignancy other than multiple myeloma within five years of vaccination or bone marrow collection, except adequately treated basal or squamous cell skin cancer
boolean
C0006826 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0026764 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0007117 (UMLS CUI [3,2])
C1522326 (UMLS CUI [3,3])
C1705847 (UMLS CUI [4,1])
C0553723 (UMLS CUI [4,2])
C1522326 (UMLS CUI [4,3])
Autoimmune Disease Requirement Systemic therapy | Rheumatoid Arthritis | Multiple Sclerosis | Lupus Erythematosus, Systemic | Hypothyroidism Without Graves Disease allowed | Hypothyroidism Without Hashimoto Disease allowed
Item
active autoimmune disease (e.g., rheumatoid arthritis, multiple sclerosis, systemic lupus erythematosis) requiring systemic treatment. hypothyroidism without evidence of grave's disease or hashimoto's thyroiditis is permitted
boolean
C0004364 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C1515119 (UMLS CUI [1,3])
C0003873 (UMLS CUI [2])
C0026769 (UMLS CUI [3])
C0024141 (UMLS CUI [4])
C0020676 (UMLS CUI [5,1])
C0332288 (UMLS CUI [5,2])
C0018213 (UMLS CUI [5,3])
C0683607 (UMLS CUI [5,4])
C0020676 (UMLS CUI [6,1])
C0332288 (UMLS CUI [6,2])
C0677607 (UMLS CUI [6,3])
C0683607 (UMLS CUI [6,4])
Compression of spinal cord
Item
evidence of spinal cord compression at time of transplant
boolean
C0037926 (UMLS CUI [1])